BB
Artwork for Breaking Biotech
Tech · General

Breaking Biotech

Hosted by Matthew Lepoire.

Should you pitch it?

Guest activity
Sometimes has guests
30% of recent episode titles look like interviews
Episode length
41 min
Median of recent episodes. That is the commitment you would be asking for.
Publishing
Dormant
10 episodes · last 2022-05-08
Language
English (US)
Declared in the feed as en-us.
Where it's from
Outside the UK
The feed declares en-us.
Reach
16
Percentile among shows you could realistically get on. Not a download count.
Check whether they charge. Some shows sell guest slots rather than booking them, and rates in some fields run to thousands. Nothing in a podcast feed reliably says so, so we do not claim either way. Ask before you write the pitch.
Worth a pitch. This show publishes its own contact, sits outside the national chart, is independently published, and its recent episodes show it books guests.

What the show says about itself

Matt goes in-depth on various biotechnology companies to find good quality trading opportunities.

Recent episodes

Straight from the feed. The quickest way to judge whether your angle fits.

  1. 113 - Vaxxinity Takes on Neurodegenerative Diseases with Vaccines - Potential Short Opportunity?
  2. 112 - Biotech Updates - $BTAI $TGTX $CRIS $CKPT $KPTI $SRRA
  3. 111 - Achieve Life Sciences Phase 3 Readout Imminent! Interview with CEO John Bencich
  4. 110 - Kodiac Sciences FALLS on Negative Wet AMD Readout! Buying Opportunity or Falling Knife??
  5. 109 - Karyopharm Guides INCREASED Sales Growth in 2022 and Reports Positive SIENDO Results
  6. 108 - NASH Companies to Watch in 2022! Madrigal Pharma Announces Positive Data in NAFLD

This show publishes a contact

We hold the address this show publishes in its own feed. Addresses and drafted pitches are part of a plan. Browsing stays free, and we never send on your behalf.

Tell me when pitching opens